Always interesting to read different views. Thanks 4$.
"Not one of those deals has been done with a company that has dosed just 14 patients with its products..."
There have been many billion dollar deals done on pre-clinical data - which is miles earlier than phase 2.
But it's also the power of the numbers. Still no phase 3 or 4 safety adverse events. A complete unheard of when it comes to cancer treatments.
Re:Re:Charts:Imugene, page-26
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
-0.001(2.04%) |
Mkt cap ! $360.7M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 5.0¢ | 4.8¢ | $378.5K | 7.735M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 82 | 10542091 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 1783345 | 29 |
View Market Depth
| Last trade - 14.50pm 08/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |